Can-Fite BioPharma Ltd. Adjustments For Reconcile Profit Loss
Can-Fite BioPharma Ltd. (CANF) reported Adjustments For Reconcile Profit Loss of -$2.20 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-03-27.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForReconcileProfitLoss · last filed 2020-03-27
| Period end | Adjustments For Reconcile Profit Loss 6 month | Adjustments For Reconcile Profit Loss 12 month | Adjustments For Reconcile Profit Loss 12 month as first filed |
|---|---|---|---|
| 2019-12-31 | -$2.20M 20-F · filed 2020-03-27 | ||
| 2019-06-30 | $252.00K 6-K · filed 2019-08-30 | ||
| 2018-12-31 | $1.28M 20-F · filed 2020-03-27 | ||
| 2018-06-30 | -$559.00K 6-K · filed 2019-08-30 | ||
| 2017-12-31 | -$542.00K 20-F · filed 2020-03-27 | -$2.10M 20-F · filed 2018-03-28 | |
| 2017-06-30 | -$378.00K 6-K · filed 2018-08-31 | ||
| 2016-12-31 | $25.00K 20-F · filed 2019-03-29 | ||
| 2015-12-31 | $223.00K 6-K · filed 2018-08-08 |